152 related articles for article (PubMed ID: 21673355)
41. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
[TBL] [Abstract][Full Text] [Related]
42. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
43. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M
Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
45. Association of Human Papillomavirus Genotype 16 Viral Variant and Viral Load with Cervical High-grade Intraepithelial Lesions.
Álvarez-Paredes L; Santibañez M; Galiana A; Rodríguez Díaz JC; Parás-Bravo P; Andrada-Becerra ME; Ruiz García MM; Rodríguez-Ingelmo JM; Portilla-Sogorb J; Paz-Zulueta M
Cancer Prev Res (Phila); 2019 Aug; 12(8):547-556. PubMed ID: 31208965
[TBL] [Abstract][Full Text] [Related]
46. HPV testing alone is not as safe as cytology and selective HPV testing: AGAINST: There is powerful evidence for primary cervical screening.
Kitchener H
BJOG; 2016 Jan; 123(1):68. PubMed ID: 26527427
[No Abstract] [Full Text] [Related]
47. Screening for cervical cancer.
CA Cancer J Clin; 2020 Sep; 70(5):347-348. PubMed ID: 33460047
[No Abstract] [Full Text] [Related]
48. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease.
Adam E; Berkova Z; Daxnerova Z; Icenogle J; Reeves WC; Kaufman RH
Am J Obstet Gynecol; 2000 Feb; 182(2):257-64. PubMed ID: 10694321
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
[TBL] [Abstract][Full Text] [Related]
50. Establishment of a national cervical screening programme in Ireland, CervicalCheck: the first 6 years.
Flannelly GM; Mooney MT; Greehy GM; Keogh EB; McNally SA; Fitzpatrick PE
Eur J Cancer Prev; 2018 Mar; 27(2):158-163. PubMed ID: 27824660
[TBL] [Abstract][Full Text] [Related]
51. HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening.
Giorgi Rossi P; Carozzi F; Collina G; Confortini M; Dalla Palma P; De Lillo M; Del Mistro A; Ghiringhello B; Gillio-Tos A; Maioli P; Pellegrini A; Schiboni ML; Segnan N; Zaffina LM; Zorzi M; Ronco G;
Am J Clin Pathol; 2012 Jul; 138(1):65-71. PubMed ID: 22706859
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
[TBL] [Abstract][Full Text] [Related]
53. [Papillomavirus screening: shall it be performed systematically?].
Agius G; Beby-Defaux A
Transfus Clin Biol; 2003 Apr; 10(2):86-9. PubMed ID: 12763151
[No Abstract] [Full Text] [Related]
54. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus testing in the prevention of cervical cancer.
Schiffman M; Wentzensen N; Wacholder S; Kinney W; Gage JC; Castle PE
J Natl Cancer Inst; 2011 Mar; 103(5):368-83. PubMed ID: 21282563
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
57. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
[TBL] [Abstract][Full Text] [Related]
58. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
59. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of a new solid media specimen transport card for high risk HPV detection and cervical cancer prevention.
Maurer K; Luo H; Shen Z; Wang G; Du H; Wang C; Liu X; Wang X; Qu X; Wu R; Belinson J
J Clin Virol; 2016 Mar; 76():14-9. PubMed ID: 26774544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
